Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
activist, advocating, affiliate, clause, CLIN, composed, developmental, disposition, driven, Dual, ETR, fiscal, iii, iv, leveraged, mouse, mutually, novated, novation, Oncoceutic, optimize, outpace, pre, prodrug, proxy, quantitatively, reader, resume, Shareholder, shift, subcontracted, subcontractor, Subpart, unplanned
Removed:
arbitration, beneficiary, black, box, boxed, capable, comprised, confirm, confirmed, disadvantage, finalization, forecasted, inherently, mechanism, mortality, negotiated, observed, obsolete, pharmacology, proposal, quantification, reconsideration, replacement, reserve, resistance, RFP, stockpiling, supplement, TPOXX, validated, vitro
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view